tiprankstipranks
Unity Biotechnology Inc (UBX)
NASDAQ:UBX
US Market

Unity Biotechnology (UBX) Income Statement

Compare
759 Followers

Unity Biotechnology Income Statement

Last quarter (Q3 2024), Unity Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Unity Biotechnology's net income was $-6.48M. See Unity Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 236.00K$ 4.78M$ 0.00
Gross Profit
$ 0.00$ -19.70M$ -1.94M$ 1.90M$ -3.45M
Operating Expenses
$ 31.17M$ 24.97M$ 57.81M$ 61.45M$ 91.33M
Depreciation and Amortization
$ 0.00$ 1.18M$ 2.18M$ 2.88M$ 3.45M
EBITDA
$ -31.17M$ -37.28M$ -38.73M$ -54.67M$ -89.10M
Operating Income
$ -31.17M$ -44.67M$ -57.57M$ -56.66M$ -93.93M
Other Income/Expenses
$ 5.18M$ 4.81M$ 13.10M$ -4.06M$ 86.00K
Pretax Income
$ -25.99M$ -39.86M$ -59.93M$ -60.73M$ -93.84M
Net Income
$ -25.99M$ -39.86M$ -57.75M$ -60.04M$ -91.87M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.54$ -2.70$ -6.08$ -10.76$ -18.06
Diluted EPS
$ -1.54$ -2.70$ -6.08$ -10.76$ -18.06
Weighted Average Shares Outstanding
16.83M 14.77M 9.49M 5.58M 5.09M
Weighted Average Shares Outstanding (Diluted)
16.83M 14.77M 9.49M 5.58M 5.09M
Currency in USD

Unity Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis